Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | -432.80K | -288.80K | -401.60K | -272.60K | -303.30K |
| Total Depreciation and Amortization | 3.50K | 4.70K | 4.70K | 4.70K | 7.00K |
| Total Amortization of Deferred Charges | 21.10K | 2.00K | 1.60K | 900.00 | 2.10K |
| Total Other Non-Cash Items | 74.20K | 27.50K | 31.30K | 22.20K | -63.10K |
| Change in Net Operating Assets | -106.00K | 180.90K | 261.70K | 145.60K | 297.80K |
| Cash from Operations | -440.00K | -73.60K | -102.30K | -99.20K | -59.40K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -2.60K | -4.50K | -500.00 |
| Cash from Investing | 0.00 | 0.00 | -2.60K | -4.50K | -500.00 |
| Total Debt Issued | 509.40K | 75.00K | 150.00K | 95.00K | 50.00K |
| Total Debt Repaid | -11.50K | -12.70K | -15.60K | -15.40K | -7.30K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.10K | -4.40K | -11.70K | -- | -- |
| Cash from Financing | 514.00K | 57.90K | 122.70K | 79.60K | 42.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.00K | -15.70K | 17.80K | -24.10K | -17.20K |
